The treatment of children with difficult-to-control epilepsy;Tratamiento de los niños con epilepsia de dificil control

Revista de Neurologia

Volumn 37, Issue 4, 2003, Pages 371-375

  Cuéllar, Rigoberto ^a,b   Molinero, M ^a  

^a Hospital Escuela   (Honduras)

^b NONE   (Honduras)

Author keywords

Antiepileptic drugs; Epilepsy; Epileptic seizures; Paediatrics; Treatment of epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; HORMONE; IMMUNOGLOBULIN; STEROID;

CONFERENCE PAPER; DIET THERAPY; DISEASE SEVERITY; DOSE RESPONSE; EPILEPSY; HUMAN; KETOGENIC DIET; NERVE STIMULATION; PEDIATRICS; SEIZURE; TREATMENT OUTCOME; TREATMENT PLANNING; VAGUS NERVE;

EID: 0141961040     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3704.2003179     Document Type: Conference Paper

References (39)

1. Holmes GL, Tae S.. EEG and clinical predictor of medically intractable childhood epilepsy. Clin Neurophysiol 1999; 110: 1245-51.
2. Berg AT, Levy SR, Norothy EJ, Shinnar S. Predictor of intractable epilepsy in childhood. a case control study. Epilepsia 1996; 37: 24-30.
3. Wyllie E. Surgical treatment of epilepsy in children. Pediatric Neurol 1998; 19: 179-88.
4. Mukaira K, Oguri H, et al. Study on surgical treatment of intractable childhood epilepsy. Brain Dev 1998; 20: 154-64.
5. Chugani HT, Shields WD. Infantile spasms: PET Identifies focal cortical dysgenesis in criptogenic cases for surgical treatment. Ann Neurol 1990; 27: 406-13.
6. Asano E, Chugari D. Surgical treatment of West syndrome. Brain Dev 2001; 23: 668-76.
7. Vinning EPG. Clinical efficacy of the ketogenic diet. Epilepsy Res 1999; 37: 181-90.
8. Ross DL, Swaiman KF, Torres F, Hausen J. Early biochemical and EEG correlates of the ketogenic diet in children with atypical absence epilepsy. Pediatric Neurol 1985; 1: 104-8.
9. Freeman JM, Vinning EPG. seizures decrease rapidly after fasting: preliminary studies of the ketogenic diet. Arch Pediatr 1999; 37: 1037-9.
10. Thompson, et al. Ketogenic diet: long term efficacy and patient tolerance in the treatment of intractable pediatric epilepsy. Epilepsia 1998; 39: 167.
11. Ito M, Akuno T, Fuji T, et al. ACTH therapy in infantile spasms: relationship between dose of ACTH and initial effect or long term prognosis. Pediatr Neurol 1999; 6: 240-4.
12. Singer WD, Rabe EF, Haller TS. The effect of ACTH therapy upon infantile spasms. J Pediatric 1980; 96: 485-9.
13. Lombroso CT. A prospective study of infantile spasms: clinical and therapeutic correlation. Epilepsia 1983; 24: 135-58.
14. Riikonen R, Donner M. ACTH therapy in infantile spasms: side effects. Arch Dis Child 1980; 55: 664-72.
15. Riikonen R. A long term follow up study of 214 children with the syndrome of intractable spasms. Neuro Pediatrics 1982; 13: 14-23.
16. Hachovy RA, et al. Double blind study of ACTH vs. prednisone therapy in infantile spasms. J Ped 1983; 103: 641-5.
17. Baram TZ, Mitchell WG, Tournay A, Snead OC, Hanson RA, Horton EJ. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics 1996; 97: 375-9.
18. Sher PK, Sheikm MR. Therapeutic efficacy of ACTH in symptomatic infantile spasms with hipsarrythmia. Pediatr Neurol 1993; 9: 451-6.
19. Bobele GB, Bodensteiner JB. The treatment of infantile spasms by child neurologists. J Child Neurol 1994; 9: 432-5.
20. Riikonen R. Current knowledge of action of ACTH and corticosteroids. Brain Dev 1987; 9: 409-14.
21. Snead OC III, Benton JW, Myers GJ. ACTH and prednisone in childhood seizures disorders. Neurology 1983; 33: 966-70.
22. Prasad AN, Stafstrom CF, Holmes GL. Alternated epilepsy therapies: the ketogenic diet, inmunoglobulins and steroids. Epilepsia 1996; 37 (Suppl 1): 589-95.
23. Fayad MN, Choueiri R, Mikati M. Landau-Kleffner syndrome; consistent response to repeated intravenous gamma-globulin doses: a case report. Epilepsia 1997; 38: 488-94.
24. Takeuchi Y, Takano T, Abe J, Takikita S, Ohno M. Thyrotropin releasing hormone: role in the treatment of West syndrome and related epileptic encephalopathies. Brain Dev 2001; 23: 662-7.
25. Selye M. The antagonism between anesthetic steroid hormones and pentamethylenetetrazol (Metrazol). J Lab Clin Med 1942; 27: 1051-3.
26. Figdor SK, Kodet MJ, et al. Central activity and structure in a series of water-soluble steroids. J Pharmacol Exp Ther 1957; 119: 299-309.
27. Graig CR. Antiepileptic activity of steroids: separability of antiepileptic from hormonal effects. J Pharmacol Exp Ther 1966; 153: 337-43.
28. Kerrigan JF, Shields WD, Nelson TY, Bluestone DL, Dodson WE, Bourgeois BF, Pellock JM, Morton LD, Monaghan EP. Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial. Epilepsy Res 2000; 42: 133-9.
29. Gross T, Shaler RS, Kazir E, et al. Intravenous gamma-globulin in intractable epilepsy of childhood. Acta Neurol Scand 1993; 88: 204-9.
30. Etzioni A, Jaffe M, Pollack S, Zelnik N, Benderly A, Tal Y. High dose intravenous gamma-globulin in intractable epilepsy of childhood. Eur J Pediatr 1991; 150: 681-3.
31. Spina A, Losito R, Marzocco P, Damato R. Treatment of intractable childhood epilepsy with high doses of intravenous gamma-globulins. Acta Neurol 1989; 11: 415-22.
32. Walker ARE. Allergic phenomena as basic mechanism in epilepsy. In Jasper HIH, Word AA Jr, Pope A, eds. Basic mechanism of the epilepsies. London: Churchill; 1969. p. 812.
33. Ettlinger G, Lownie MB. An inmunological factor in epilepsy. Lancet 1976; 1: 1386.
34. Aarly JA. Epilepsy and the immune system. Arch Neurol 2000; 57: 1689-92.
35. Andermann E, Oguri H, et al. Genetic aspects of chronic encephalitis. In Andermann F, et al, eds. Chronic encephalitis and epilepsy: Rasmussen's syndrome. Oxford: Butterworth-Heinemann; 1991. p. 167-75.
36. Rogers SW, Andrews PI, Gahring LC, Whisenand T, Cauley K, Crain B, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994; 265: 648-51.
37. Valencia I, Holder DL, Helmers SL, Madsen JR, Riviello JJ Jr. Vagus nerve stimulation in pediatric epilepsy: a review. Pediatric Neur 2001; 25: 368-76.
38. Singler M, Strassrsurg H, Boenigk H. Effective and safe but forgotten: methsuximide in intractable epilepsies in childhood. Seizure 2001; 10: 120-4.
39. Takayanagi M, Yamamoto K, Nakagawa H, Munakata M, Kato R, Yokoyama H, et al. Two successful cases of bromide therapy for refractory symptomatic localization-related epilepsy. Brain Dev 2002; 24: 194-6.